The Inhibitory Effects of Pure Flavonoids on in Vitro Protein Glycosylation

References

• Foster D W. Diabetes Mellitus. Harrison's Principles of Internal Medicine, K J Isselbacher, E Braunwald, J D Wilson, J B Martin, D L Kasper. MCGraw-Hill, New York 1994; 1979–2000
   Google Scholar
• Garber A J. Diabetes Mellitus. Internal Medicine. 5th ed., J H Stein. Mosby, Phila-delphia 1998; 1851
   Google Scholar
• Chase H P, Jackson W E, Hoops S L, Cockerham R S, Archer P G, O'Brein D. Glucose control and the renal and retinal complications of insulin-dependent diabetes. JAMA 1989; 261(8)1155–60
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Am Intern Med 1995; 122: 501–8
   Google Scholar
• Fox C J, et al. Studies of unusual hemoglobin in patients with diabetes mellitus. Br Med J. 1997; 2: 605–7
   Google Scholar
• Friedman E, Rodby R, Cerami A, Bucala R. Hemoglobin-AGE: A circulating marker of advanced glycosylation. Science 1992; 258(5082)651–3
   PubMed Web of Science ®Google Scholar
• Bucala R, Cerami A. Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging. Adv Pharmacol. 1992; 23: 1–34
   PubMedGoogle Scholar
• Bunn H F. Evaluation of glycosylated hemoglobin in diabetic proteins. Diabetes. 1981; 30(7)613–7
   PubMed Web of Science ®Google Scholar
• Nathan D M, Singer D E, Hurxthal K, Goodson J D. The clinical information value of glycosylated hemoglobin assay. N Engl J Med. 1984; 310: 341–6
   PubMed Web of Science ®Google Scholar
• Vlassara H, Brownlee M, Cerami A. Non-enzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc Natl Acad Sci USA. 1981; 78(8)5190–2
   PubMed Web of Science ®Google Scholar
• Bucala R, Makita Z, Koschinsky T, Cerami A, Valssara H. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA. 1993; 90(14)6434–8
   PubMed Web of Science ®Google Scholar
• Watala C, Witas H, Olszowska L, Piasecki W. The association between eryth-rocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitus. Int J Exp Pathol. 1992; 73(5)655–63
   PubMed Web of Science ®Google Scholar
• Bailey A J, Robins S P, Tanner M J. Reducible components in the proteins of human erythrocyte membrane. Biochim Biophys Acta. 1976; 434(1)51–7
   PubMed Web of Science ®Google Scholar
• Wolff S P. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull. 1993; 49: 645–52
   Google Scholar
• Liang J N, Chylack L T, Jr. Change in the protein tertiary structure with non-enzymatic glycosylation of calf alpha-crystallin. Biochem Biophys Res Commun. 1984; 123(3)899–906
   PubMed Web of Science ®Google Scholar
• Defronzo R A. Current Therapy of Diabetes Mellitus. Mosby-Yearbook, Inc., Philadelphia 1998; 51–52
   Google Scholar
• Kohn R R, Cerami A, Monnier V M. Collagen aging in vitro by non-enzymatic glycosylation and browning. Diabetes 1984; 33: 57–9
   PubMed Web of Science ®Google Scholar
• Fairbanks V F, Klee G G. Biochemical aspects of hemotology. Tietz Textbook of Clinical Chemistry. 2nd ed., C A Burtis, E R Ashwood. WB Saunders Company, Philadelphia 1994; 2020–2030
   Google Scholar
• Van Kampen E J, Zijlstra W G. Determination of hemoglobin and its derivatives. Adv Clin Chem 1965; 8: 141–187
   PubMedGoogle Scholar
• Griffin J W. Metabolic neuropathies. CECIL Textbook of Medicine, 21st ed., G Bennett. WB Saunders, Philadelphia 2000; 2197
   Google Scholar
• Afanas'ev I B, Dorozhko A I, Brodskii A V, Kostyuk V A, Potapovitch A I. Che-lating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol. 1989; 38(11)1763–9
   PubMed Web of Science ®Google Scholar
• Sorata Y, Takahama U, Kimata M. Protective effect of quercetin and rutin on photosensitized lysis of human erythrocytes in the presence of hematoporphyrin. Biochim Biophys Acta. 1984; 799(3)313–7
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge J M, Cross C E. Free radicals, antioxidants, and human disease: Where are we now?. J Lab Clin Med. 1992; 119(6)598–620
   PubMed Web of Science ®Google Scholar
• Mora A, Paya M, Rios J L, Alcaraz M J. Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxi-dation. Biochem Pharmacol. 1990; 40(4)793–7
   PubMed Web of Science ®Google Scholar
• Samuelsson G. Drugs of Natural Origin. 4th ed. Swedish Pharmaceutical Press, Stockholm 1999; 226–227
   Google Scholar
• Middlton E, Kandaswami C. The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. The Flavonoid Advances Research Since 1986, J B Harborne. Chapman & Hall, London 1994; 619–52
   Google Scholar
• Asgary S, Naderi G H, Sarraf-Zadegan N, Ghassemi N, Boshtam M, Rafie M, Arefian A. Anti-oxidant effect of flavonoids on hemoglobin glycosylation. Pharm Acta Helv. 1999; 73(5)223–6
   PubMedGoogle Scholar
• Fluckiger R, Winterhalter K H. Biochemical and Clinical Aspects of Hemoglobin Abnormalities. Academic Press, New York 1978; 208
   Google Scholar